WHO ICTRP trial
A phase 1 pharmacokinetic study to assess and compare the relative…
NL-OMON50260 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON50260 |
|---|---|
| Public title | A phase 1 pharmacokinetic study to assess and compare the relative bioavailability of a capsule and a tablet formulation of YTX-7739 following single oral doses administered with and without food in Healthy Volunteers |
| Scientific title | A phase 1 pharmacokinetic study to assess and compare the relative bioavailability of a capsule and a tablet formulation of YTX-7739 following single oral doses administered with and without food in Healthy Volunteers - YTX-7739 formulation study |
| Primary sponsor | Yumanity Therapeutics |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Parkinson's Disease;10028037;Parkinson's Disease |
| Interventions | Treatment period 1: 30 mg YTX-7739 tablet formulation (2 tablets of 15mg). Treatment period 2: 30 mg YTX-7739 capsule formulation (2 capsules, 1x25mg, 1x5 mg) Treatment period 3: 30 mg YTX-7739 tablet formulation (2 tablets of 15mg), after… |
| Registration date | Jan 6, 2022 |
| Target size | 16 |
| Secondary IDs | 2021-004754-28;NL78956.056.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: